Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model.
Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model. Anticancer Res. 2015 Jan; 35(1):47-52.
View in:
PubMed
subject areas
Animals
Animals
Antineoplastic Agents
Antineoplastic Agents
Breast Neoplasms
Breast Neoplasms
Female
Female
Humans
Humans
MCF-7 Cells
MCF-7 Cells
Mice, Inbred BALB C
Mice, Inbred BALB C
Mice, Nude
Mice, Nude
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Receptor, Fibroblast Growth Factor, Type 2
Receptor, Fibroblast Growth Factor, Type 2
Tumor Burden
Tumor Burden
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Megan Ross Lerner
Meghna Divyesh Mehta